Literature DB >> 26302976

Intraoperative blood loss is not a predictor of prognosis for pancreatic cancer.

Kota Arima1, Daisuke Hashimoto1, Hirohisa Okabe1, Risa Inoue1, Takayoshi Kaida1, Takaaki Higashi1, Katsunobu Taki1, Hidetoshi Nitta1, Hiromitsu Hayashi1, Akira Chikamoto1, Toru Beppu1, Hideo Baba2.   

Abstract

PURPOSE: The relationship between intraoperative blood loss (IBL) and prognosis has been reported for some types of cancer, but not for pancreatic cancer, which has one of the highest mortality rates of any cancer. We conducted this study to analyze the relationship between IBL and clinical outcome for patients undergoing radical surgery for pancreatic cancer.
METHODS: The subjects of this study were 144 patients who underwent curative pancreatectomy for invasive pancreatic cancer between 2002 and 2014. Clinicopathological characteristics were recorded and prognostic factors were identified by univariate and multivariate analyses.
RESULTS: Large IBL was significantly associated with advanced tumor stage, a long operation time, a large tumor, portal vein resection, and blood transfusion. According to univariate analysis, IBL was also significantly associated with overall survival (OS) and relapse-free survival (RFS); however, it was not an independent prognostic factor for OS and RFS in multivariate analysis. According to multivariate analysis, lymph node metastasis and R-status were independent prognostic factors for OS and RFS. A subgroup analysis of patients who received no blood transfusion showed similar results.
CONCLUSION: Minimizing IBL is very important; however, the present study found that positive lymph node metastasis and R-status were stronger independent prognostic factors for pancreatic cancer.

Entities:  

Keywords:  Intraoperative blood loss; Pancreatic cancer; Surgery

Mesh:

Year:  2015        PMID: 26302976     DOI: 10.1007/s00595-015-1238-8

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  23 in total

Review 1.  Laparoscopic distal pancreatosplenectomy for pancreatic ductal adenocarcinoma.

Authors:  Tamotsu Kuroki; Susumu Eguchi
Journal:  Surg Today       Date:  2014-08-26       Impact factor: 2.549

2.  Pancreaticodigestive anastomosis and the postoperative management strategies to prevent postoperative pancreatic fistula formation after pancreaticoduodenectomy.

Authors:  Daisuke Hashimoto; Akira Chikamoto; Masaki Ohmuraya; Masahiko Hirota; Hideo Baba
Journal:  Surg Today       Date:  2013-07-11       Impact factor: 2.549

3.  Resectable pancreatic cancer: who really benefits from resection?

Authors:  Giuliano Barugola; Stefano Partelli; Stefano Marcucci; Nora Sartori; Paola Capelli; Claudio Bassi; Paolo Pederzoli; Massimo Falconi
Journal:  Ann Surg Oncol       Date:  2009-12       Impact factor: 5.344

Review 4.  Treatment for pancreatic cancer: current therapy and continued progress.

Authors:  A Craig Lockhart; Mace L Rothenberg; Jordan D Berlin
Journal:  Gastroenterology       Date:  2005-05       Impact factor: 22.682

5.  Impact of operative blood loss on survival in invasive ductal adenocarcinoma of the pancreas.

Authors:  Shunji Nagai; Tsutomu Fujii; Yasuhiro Kodera; Mitsuro Kanda; Tevfik T Sahin; Akiyuki Kanzaki; Suguru Yamada; Hiroyuki Sugimoto; Shuji Nomoto; Shin Takeda; Satoshi Morita; Akimasa Nakao
Journal:  Pancreas       Date:  2011-01       Impact factor: 3.327

6.  National failure to operate on early stage pancreatic cancer.

Authors:  Karl Y Bilimoria; David J Bentrem; Clifford Y Ko; Andrew K Stewart; David P Winchester; Mark S Talamonti
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

7.  Prognostic factors after resection of pancreatic cancer.

Authors:  Michio Ueda; Itaru Endo; Masayuki Nakashima; Yuta Minami; Kazuhisa Takeda; Kenichi Matsuo; Yasuhiko Nagano; Kuniya Tanaka; Yasushi Ichikawa; Shinji Togo; Chikara Kunisaki; Hiroshi Shimada
Journal:  World J Surg       Date:  2009-01       Impact factor: 3.352

8.  Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma.

Authors:  M Wagner; C Redaelli; M Lietz; C A Seiler; H Friess; M W Büchler
Journal:  Br J Surg       Date:  2004-05       Impact factor: 6.939

9.  Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases.

Authors:  David A Kooby; Jennifer Stockman; Leah Ben-Porat; Mithat Gonen; William R Jarnagin; Ronald P Dematteo; Scott Tuorto; David Wuest; Leslie H Blumgart; Yuman Fong
Journal:  Ann Surg       Date:  2003-06       Impact factor: 12.969

Review 10.  Perioperative blood transfusions for the recurrence of colorectal cancer.

Authors:  A Amato; M Pescatori
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25
View more
  17 in total

1.  The Impact of Intraoperative Blood Loss on the Survival of Patients With Stage II/III Pancreatic Cancer.

Authors:  Hiroshi Tamagawa; Toru Aoyama; Naoto Yamamoto; Mariko Kamiya; Masaaki Murakawa; Yosuke Atsumi; Masakatsu Numata; Keisuke Kazama; Kentaro Hara; Norio Yukawa; Yasushi Rino; Munetaka Masuda; Soichiro Morinaga
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  A comparative study on the complications of conventional and end-to-side inserting pancreatojejunostomy after pancreaticoduodenectomy.

Authors:  Daisuke Hashimoto; Akira Chikamoto; Norifumi Harimoto; Toru Ikegami; Hideaki Uchiyama; Tomoharu Yoshizumi; Hideo Baba; Yoshihiko Maehara
Journal:  Surg Today       Date:  2016-06-09       Impact factor: 2.549

3.  Necessity for autologous blood storage and transfusion in patients undergoing pancreatoduodenectomy.

Authors:  Yoshito Tomimaru; Kozo Noguchi; Keizo Dono
Journal:  Surg Today       Date:  2016-08-22       Impact factor: 2.549

Review 4.  Attempts to prevent postoperative pancreatic fistula after distal pancreatectomy.

Authors:  Yoshihiro Miyasaka; Yasuhisa Mori; Kohei Nakata; Takao Ohtsuka; Masafumi Nakamura
Journal:  Surg Today       Date:  2016-06-20       Impact factor: 2.549

5.  Safety and efficacy of postoperative pharmacologic thromboprophylaxis with enoxaparin after pancreatic surgery.

Authors:  Hajime Imamura; Tomohiko Adachi; Amane Kitasato; Takayuki Tanaka; Akihiko Soyama; Masaaki Hidaka; Fumihiko Fujita; Mitsuhisa Takatsuki; Tamotsu Kuroki; Susumu Eguchi
Journal:  Surg Today       Date:  2017-02-22       Impact factor: 2.549

6.  Significance of lymph node metastasis in pancreatic neuroendocrine tumor.

Authors:  Katsunobu Taki; Daisuke Hashimoto; Shigeki Nakagawa; Nobuyuki Ozaki; Shinjiro Tomiyasu; Masaki Ohmuraya; Kota Arima; Takayoshi Kaida; Takaaki Higashi; Keita Sakamoto; Kazuya Sakata; Hirohisa Okabe; Hidetoshi Nitta; Hiromitsu Hayashi; Akira Chikamoto; Toru Beppu; Hiroshi Takamori; Masahiko Hirota; Hideo Baba
Journal:  Surg Today       Date:  2017-02-22       Impact factor: 2.549

7.  Exposure to Blood Components and Inflammation Contribute to Pancreatic Cancer Progression.

Authors:  Ryo Saito; Hiromichi Kawaida; Naohiro Hosomura; Hidetake Amemiya; Jun Itakura; Atsushi Yamamoto; Koichi Takiguchi; Suguru Maruyama; Katsutoshi Shoda; Shinji Furuya; Hidenori Akaike; Yoshihiko Kawaguchi; Makoto Sudo; Shingo Inoue; Hiroshi Kono; Daisuke Ichikawa
Journal:  Ann Surg Oncol       Date:  2021-06-08       Impact factor: 5.344

8.  The impact of margin status determined by the one-millimeter rule on tumor recurrence and survival following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.

Authors:  Takeo Nitta; Toru Nakamura; Tomoko Mitsuhashi; Toshimichi Asano; Keisuke Okamura; Takahiro Tsuchikawa; Eiji Tamoto; Soichi Murakami; Takehiro Noji; Yo Kurashima; Yuma Ebihara; Yoshitsugu Nakanishi; Toshiaki Shichinohe; Satoshi Hirano
Journal:  Surg Today       Date:  2016-09-27       Impact factor: 2.549

9.  Details and Outcomes of Distal Pancreatectomy with Celiac Axis Resection Preserving the Left Gastric Arterial Flow.

Authors:  Yosuke Inoue; Akio Saiura; Takafumi Sato; Atsushi Oba; Yoshihiro Ono; Yoshihiro Mise; Hiromichi Ito; Yu Takahashi
Journal:  Ann Surg Oncol       Date:  2021-06-18       Impact factor: 5.344

10.  Perioperative Glucocorticoids are Associated with Improved Recurrence-Free Survival After Pancreatic Cancer Surgery: A Retrospective Cohort Study with Propensity Score-Matching.

Authors:  Yun-Xiao Zhang; Dong-Liang Mu; Ke-Min Jin; Xue-Ying Li; Dong-Xin Wang
Journal:  Ther Clin Risk Manag       Date:  2021-01-22       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.